Jerry Mclaughlin
President and Chief Executive Officer
AgeneBio
United States of America
Biography
Jerry McLaughlin is the President and Chief Executive Officer of AgeneBio, and he served as the Senior Vice President and Chief Commercial Officer of NuPathe Inc. until the company was acquired by Teva Pharmaceuticals Industries Ltd. in 2014. He has served as our President and Chief Executive Officer since June 2014. He has 27 years of executive, operational and commercial leadership experience in the biopharmaceutical industry and also served in a variety of commercial leadership roles at Merck from 1990 to 2001 and Endo Pharmaceuticals from 2001 to 2007. He holds a BA in Economics from Dickinson College and an MBA from Villanova University.
Research Interest
neuroscience and the neurobiology, Alzheimer’s disease, brain aging
